NASDAQ:SLP Simulations Plus (SLP) Stock Price, News & Analysis $15.37 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$15.37 0.00 (0.00%) As of 05/22/2026 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Simulations Plus Stock (NASDAQ:SLP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Simulations Plus alerts:Sign Up Key Stats Today's Range$15.13▼$15.5950-Day Range$11.36▼$16.6852-Week Range$11.09▼$34.01Volume171,303 shsAverage Volume369,113 shsMarket Capitalization$310.55 millionP/E RatioN/ADividend YieldN/APrice Target$24.40Consensus RatingHold Company Overview Simulations Plus, Inc. (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics. In addition to software sales, Simulations Plus offers consulting services, training and custom model development to support drug discovery and development projects from preclinical through clinical stages. Founded in 1996 and headquartered in Lancaster, California, Simulations Plus has expanded its global footprint by serving clients across North America, Europe and Asia. The company’s software solutions are used by pharmaceutical and biotech firms, academic institutions and regulatory agencies to optimize formulation strategies, anticipate drug interactions and reduce the time and cost associated with in-lab or in-vivo studies. Over time, Simulations Plus has enhanced its product suite with modules for immunogenicity, absorption modeling and physiologically based pharmacokinetics, reflecting ongoing investment in research and development. Under the leadership of founder and Chief Executive Officer Walter Woltosz, Simulations Plus maintains a focus on innovation and scientific rigor. The management team combines expertise in pharmacology, computational chemistry and engineering to deliver integrated solutions that help clients make data-driven decisions. By offering regular software updates, customer support and continuing education programs, the company seeks to stay at the forefront of modeling and simulation technologies for the life sciences sector.AI Generated. May Contain Errors. Read More Simulations Plus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreSLP MarketRank™: Simulations Plus scored higher than 51% of companies evaluated by MarketBeat, and ranked 406th out of 626 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingSimulations Plus has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 3 buy ratings, 6 hold ratings, and 1 sell rating.Upside PotentialSimulations Plus has a consensus price target of $24.40, representing about 58.8% upside from its current price of $15.37.Amount of Analyst CoverageSimulations Plus has only been the subject of 2 research reports in the past 90 days.Read more about Simulations Plus' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth11.76% Earnings GrowthEarnings for Simulations Plus are expected to grow by 11.76% in the coming year, from $0.85 to $0.95 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Simulations Plus is -4.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Simulations Plus is -4.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSimulations Plus has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Simulations Plus' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.00% of the float of Simulations Plus has been sold short.Short Interest Ratio / Days to CoverSimulations Plus has a short interest ratio ("days to cover") of 4.14.Change versus previous monthShort interest in Simulations Plus has recently increased by 6.16%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldSimulations Plus does not currently pay a dividend.Dividend GrowthSimulations Plus does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Simulations Plus will have a dividend payout ratio of 25.26% next year. This indicates that Simulations Plus will be able to sustain or increase its dividend.Read more about Simulations Plus' dividend. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Simulations Plus this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for SLP on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat Follows1 people have added Simulations Plus to their MarketBeat watchlist in the last 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Simulations Plus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,370.00 in company stock.Percentage Held by Insiders19.10% of the stock of Simulations Plus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions78.08% of the stock of Simulations Plus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Simulations Plus' insider trading history. Receive SLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Simulations Plus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLP Stock News HeadlinesSimulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of "Hold" from BrokeragesMay 22 at 2:14 AM | americanbankingnews.comSimulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor ConferenceMay 21, 2026 | businesswire.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.May 25 at 1:00 AM | InvestorPlace (Ad)Simulations Plus (NASDAQ:SLP) Raised to "Buy" at Wall Street ZenMay 16, 2026 | americanbankingnews.comSimulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling WorkflowsMay 6, 2026 | businesswire.comDo options traders know something about Simulations Plus stock we don't?May 4, 2026 | msn.comSimulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug ProductsApril 21, 2026 | businesswire.comHere’s Simulations Plus Inc (SLP)’s Vision for AI in Drug DevelopmentApril 21, 2026 | finance.yahoo.comSee More Headlines SLP Stock Analysis - Frequently Asked Questions How have SLP shares performed this year? Simulations Plus' stock was trading at $18.23 at the start of the year. Since then, SLP shares have decreased by 15.7% and is now trading at $15.37. How were Simulations Plus' earnings last quarter? Simulations Plus, Inc. (NASDAQ:SLP) announced its quarterly earnings data on Thursday, April, 9th. The technology company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.08. The technology company earned $24.29 million during the quarter, compared to analysts' expectations of $21.66 million. Simulations Plus had a negative net margin of 77.96% and a positive trailing twelve-month return on equity of 16.21%. Read the conference call transcript. Who are Simulations Plus' major shareholders? Top institutional investors of Simulations Plus include First Light Asset Management LLC (13.03%), Dimensional Fund Advisors LP (1.45%), North Star Investment Management Corp. (0.98%) and Bank of America Corp DE (0.93%). Insiders that own company stock include Walter S Woltosz, John Anthony Dibella II, John Anthony Dibella II, Lisa Lavange, Daniel L Weiner and John Kenneth Paglia. View institutional ownership trends. How do I buy shares of Simulations Plus? Shares of SLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Simulations Plus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Simulations Plus investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings4/09/2026Today5/25/2026Next Earnings (Estimated)7/13/2026Fiscal Year End8/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, SLP's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry COMP - SOFTWARE Sub-IndustryComputer Software Current SymbolNASDAQ:SLP CIK1023459 Webwww.simulations-plus.com Phone(661) 723-7723Fax661-723-5524Employees160Year Founded1996Price Target and Rating Average Price Target for Simulations Plus$24.40 High Price Target$36.00 Low Price Target$16.00 Potential Upside/Downside+58.8%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($3.13) Trailing P/E RatioN/A Forward P/E Ratio18.08 P/E GrowthN/ANet Income-$64.72 million Net Margins-77.96% Pretax Margin-82.32% Return on Equity16.21% Return on Assets15.00% Debt Debt-to-Equity RatioN/A Current Ratio5.47 Quick Ratio5.47 Sales & Book Value Annual Sales$80.54 million Price / Sales3.86 Cash Flow$1.43 per share Price / Cash Flow10.74 Book Value$6.20 per share Price / Book2.48Miscellaneous Outstanding Shares20,205,000Free Float16,346,000Market Cap$310.55 million OptionableOptionable Beta1.28 Social Links Don't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:SLP) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simulations Plus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Simulations Plus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
